["Severity": "Moderate Or Severe"]

Performance/Reporting Period

2021

Value Set Description from VSAC

Clinical Focus: This value set contains concepts that represent severe and moderate levels of severity.
Data Element Scope: This value set may use Quality Data Model (QDM) attribute related to Severity.
Inclusion Criteria: Includes only relevant concepts associated with specific to severe and moderate levels of severity.
Exclusion Criteria: No exclusions.

Constrained to codes in the Severity: Moderate Or Severe value set (2.16.840.1.113883.3.526.3.1092)

QDM Attribute and Definition (QDM Version 5.5 Guidance Update)

severity

Indicates the intensity of the specified datatype (e.g., persistent, moderate, or severe).

eCQMs using this data element:

CMS144v9 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS145v9 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)

CMS135v9 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)